Stocks · Health care · Pharmaceutical Preparations

OCULAR THERAPEUTIX, INC

OCUL Clue Score42
United States Fiscal year ends December CIK 0001393434 Results filed 3 Aug 2026

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
Todd Anderman
8 Oct 2026
Chief Legal Officer
Sold on a plan
11,984
$7.29
$87.36K

What was left out

Form 4 filings counted 3
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 31 Jul 2014